TRPC5
ENSG00000072315
Target class
Ion channel
Chromosome
X
- Chemical probe available
- Yes
- Other names
- PPP1R159
- Target name
- TRPC5
- Gene name
- Transient receptor potential cation channel subfamily C member 5
- Gene symbol
- TRPC5
- Protein name
- Short transient receptor potential channel 5 (TrpC5) (Transient receptor protein 5) (TRP-5) (hTRP-5) (hTRP5)
- Gene biotype
- Protein coding
- Gene family
- Transient receptor potential cation channels|Ankyrin repeat domain containing|Protein phosphatase 1 regulatory subunits
- Target class
- Ion channel
- Target type
- Human gene
- Tissues expressed in
- 0
- Highest tissue expression
- 0.44
- Tissue specificity (Gini)
- 0.76
- Tissue specificity (tau)
- 0.898
- KEGG gene identifiers
- hsa:7224
- Protein interaction confidence
- 0.826758
- Protein interaction partners
- 33
- R-HSA-3295583
- R-HSA-418890
- End position
- 112082776
- Start position
- 111768011
- Chromosome
- X
- Strand
- Reverse
- Cell membrane
- Multi-pass membrane protein .
- PubMed 16284075
- PubMed 38959890
- PubMed 37137991
- Tissue specificity (tau)
- 0.89837
- Expression inequality (Gini)
- 0.759655
Expression in transcripts per million
- Brain - Frontal Cortex (BA9)
- 0.44
- Brain - Hypothalamus
- 0.37
- Brain - Cortex
- 0.34
- Brain - Cerebellum
- 0.24
- Brain - Anterior cingulate cortex (BA24)
- 0.21
Expression in transcripts per million
- Brain - Frontal Cortex (BA9)0.44
- Brain - Hypothalamus0.37
- Brain - Cortex0.34
- Brain - Cerebellum0.24
- Brain - Anterior cingulate cortex (BA24)0.21
- Brain - Cerebellar Hemisphere0.17
- Brain - Hippocampus0.15
- Liver0.13
- Brain - Substantia nigra0.11
- Brain - Amygdala0.1
- Esophagus - Gastroesophageal Junction0.06
- Brain - Spinal cord (cervical c-1)0.05
- Brain - Caudate (basal ganglia)0.05
- Brain - Putamen (basal ganglia)0.05
- Brain - Nucleus accumbens (basal ganglia)0.04
- Pituitary0.03
- Testis0.03
- Fallopian Tube0.02
- Cervix - Ectocervix0.02
- Cells - EBV-transformed lymphocytes0.02
- Kidney - Medulla0.02
- Esophagus - Muscularis0.02
- Thyroid0.01
- Vagina0.01
- Skin - Sun Exposed (Lower leg)0.01
And 29 more, listed on the interactive page.
- GO:0006816
- GO:0007399
- GO:0070588
- GO:0005886
- GO:0034704
- GO:0005262
- GO:0005515
- GO:0015279
Related records
Trials (1,343)
- 05-001: Treatment of Acute Lymphoblastic Leukemia in Children
- 11ß-HSD1 and Metabolic Syndrome
- 17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor
- 36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI
- 6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
- 99Tc-MDP for Thyroid-Associated Ophthalmopathy
- A 3-arm Multi-center, Randomized Controlled Study Comparing Transforaminal Corticosteroid, Transforaminal Etanercept and Transforaminal Saline for Lumbosacral Radiculopathy
- A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets
- A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets Under Fasting Conditions
- A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions
- A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
- A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)
- A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor
- A Comparative Study Between Dexmedetomidine Versus Methylprednisolone on Induced Inflammatory Response in Patients Undergoing On-pump CABG
- A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome
- A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study
- A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.
- A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression
- A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
- A Lifestyle and Combination Medication Therapy Diabetes Prevention Study
Drugs (11)
- Chlorpromazine
- Clemizole
- Daidzein
- Flufenamic acid
- Genistein
- Methylprednisolone
- Progesterone
- Riluzole
- Rosiglitazone
- SK&F-96365
- Zerencotrep